Skip to main content

Featured

More HZMB private car quotas set

The governments of Hong Kong and Macau have agreed to increase the regular quotas for Hong Kong cross-boundary non-commercial private cars using the Hong Kong-Zhuhai-Macao Bridge to Macau, the Transport Department announced today.   The decision was made to enhance traffic flow between Hong Kong and Macau, better utilising the bridge, the department said.   It will increase the Hong Kong quota by 1,000, following the earlier quota allocation of 1,800 for Hong Kong.   The additional quota will be distributed in two phases from the second quarter.   Half of the additional 1,000 quota allocations is for company applicants and the other half is for individual applicants. The quotas are valid for no more than three years. The eligibility criteria of quota applications remains the same.   Private cars allocated with Hong Kong quotas will be permitted to access the city of Macau multiple times using the bridge.   The Hong Kong quota allotments will be re-allocated upon expiry thro

Testing unaffected by virus mutation

Secretary for Food & Health Prof Sophia Chan today said the reagent used by the Public Health Laboratory Services Branch for COVID-19 testing is not affected by the genetic transformation of the virus’ S protein.   She told legislators the laboratory services branch under the Centre for Health Protection is currently using the polymerase chain reaction (PCR) nucleic acid test to conduct and process COVID-19 testing.   On vaccine procurement, Prof Chan said the vaccines advance purchased by the Government are the inactivated virus vaccine by Sinovac Biotech (Hong Kong), the nucleic acid vaccine by Fosun Pharma/German drug developer BioNTech, and the viral vector vaccine by AstraZeneca/University of Oxford.   The health chief noted the Government’s goal is to procure at least one vaccine from each vaccine technology platform. This means it will purchase four different vaccines, with the aggregate number of doses sufficient to serve at least two times the city’s population.   This is to diversify risks and ensure sufficient supplies of safe and efficacious vaccines for the whole of Hong Kong, Prof Chan added.
http://dlvr.it/RrS93B

Popular Posts